Nuclea has developed a proprietary technology which helps to identify protein or peptide biomarkers of disease directly from whole tissue samples, a process that is still highly valuable despite significant advances in both genomics and proteomics. By combining proteomics methodologies with high-throughout genomic analysis, this technology eliminates the need for protein purification and greatly increases efficiency. Thus, it makes possible the rapid identification of proteins that play significant roles in disease, many of which will become novel drug targets or diagnostic markers.

 

Antibody Array Pan -Tyrosine Kinase: 30 Antibod	Price: Please Inquire
Antibody Array Receptor pan MAPKAP Kinase 30 Antibodies	Price: Please Inquire
Antibody Array Receptor pan PI3 Kinase 30 Antibodies	Price: Please Inquire
Antibody Array Receptor pan all three above antibodies 30 Antibodies	Price: Please Inquire
Antibody Array Pan -Custom:	Price: Quoted on a per project basis

Targeted Antibodies from
Nuclea Biomarkers

Starter Sets - 50ug
Antibody

Full Antibody-300ug
Antibody

Custom Aliquots
Please

Targeted Antibodies from
Nuclea Biomarkers: Antibodies for the New Proteomics

Nuclea Biomarkers, LLC
105 South St.
Pittsfield, MA 01201

Phone: 413-749-4705
Fax: 413-445-9930